| Total (N = 48) | Non-sepsis (n = 25) | Sepsis (n = 23) | p-value |
---|---|---|---|---|
Age (years), median (range) | 65 (37–92) | 58 (37–91) | 65 (40–92) | 0.200 |
Sex, n (%) | Â | Â | Â | 1.000 |
 Male | 27 (56.3%) | 14 (56.0%) | 13 (56.5%) |  |
 Female | 21 (43.8%) | 11 (44.0%) | 10 (43.5%) |  |
Hypertension, n (%) | 16 (33.3%) | 9 (36.0%) | 7 (30.4%) | 0.765 |
CVD, n (%) | 1 (2.1%) | 1 (4.0%) | 0 (0.0%) | 1.000 |
DM, n (%) | 10 (20.8%) | 5 (20.0%) | 5 (21.7%) | 1.000 |
APACHE II score, median (range) | 22 (4–32) | 20 (4–32) | 25 (17–32) | 0.017* |
SOFA score, median (range) | 8 (2–24) | 4 (2–24) | 12 (5–21) |  < 0.001* |
Infectious shock, n (%) | 15 (31.3%) | 0 (0.0%) | 15 (65.2%) |  < 0.001* |
Multiple organ failure, n (%) | 5 (10.4%) | 0 (0.0%) | 5 (21.7%) | 0.020* |
CRP (mg/L), median (range) | 241.5 (4.9–365.9) | 167.0 (4.9–365.9) | 257.3 (36.4–355.8) | 0.040* |
PCT (ng/mL), median (range) | 21.8 (0.1–100.0) | 2.3 (0.1–85.0) | 62.3 (3.9–100.0) |  < 0.001* |
WBC (× 109/L), median (range) | 16.8 (2.3–61.7) | 15.5 (4.7–37.3) | 19.9 (2.3–61.7) | 0.044* |
MDA (nmol/mL), median (range) | 29.4 (0.6–361.7) | 11.8 (0.6–361.7) | 51.8 (2.6–263.9) | 0.011* |
SOD (U/mL), median (range) | 22.0 (0.3–118.9) | 40.3 (0.3–118.9) | 20.3 (3.3–101.2) | 0.040* |
GSH-Px (IU), median (range) | 1583.0 (555.6–3787.8) | 2350.4 (555.6–3737.4) | 1479.2 (638.9–3787.8) |  < 0.001* |
MiR-27a, median (range) | 1.0 (0.1–3.5) | 0.7 (0.1–2.1) | 1.2 (0.2–3.5) | 0.010* |
28-day mortality, n (%) | 25 (52.1%) | 9 (36.0%) | 16 (69.6%) | 0.025* |
ICU stay, median (range) | 9 (1–71) | 13 (2–71) | 8 (1–48) | 0.230 |
Hospital stat, median (range) | 16 (1–71) | 19 (2–71) | 13 (1–54) | 0.160 |